Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the utility of long-acting liposomal bupivacaine (Exparel®) in
improving pain scores and reducing narcotic pain requirements in pediatric patients following
minor urologic procedures.